Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Clinical Immunology (Orlando, Fla.)|September 19, 2017
Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndromeAdrianos Nezos, Ilir Cinoku, Clio P Mavragani, et al.
The Journal of Rheumatology|February 17, 2007
Ill-defined neurological syndromes with autoimmune background: a diagnostic challengeClio P Mavragani, Nicholas Patronas, Marinos Dalakas, et al.
Mediterranean Journal of Rheumatology|August 27, 2021
B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated AtherosclerosisNikolaos Kintrilis, Adrianos Nezos, Evangelos Theodorou, et al.
American Journal of Hematology|May 28, 2004
Cutaneous ulcers: An unusual manifestation of inherited thrombophiliaClio P Mavragani, Dimitris Pikazis, Kyriaki Aroni, et al.
Journal of Clinical Medicine|June 12, 2026
Early Cardiac Involvement in Treatment-Naïve, Autoantibody-Seropositive Patients with Autoimmune Rheumatic Diseases in the Prodromal Phase-A Cardiovascular Magnetic Resonance StudyGeorge Markousis-Mavrogenis, Vasiliki Koulouri, Clio P Mavragani, et al.
Arthritis and Rheumatism|January 30, 2010
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohortClio P Mavragani, Dan T La, William Stohl, et al.
Arthritis Research & Therapy|November 10, 2010
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective studyKaterina Laskari, Clio P Mavragani, Athanasios G Tzioufas, et al.
Expert Review of Clinical Immunology|June 7, 2021
Type I interferon detection in autoimmune diseases: challenges and clinical applicationsVassilis E Papadopoulos, Charalampos Skarlis, Maria-Eleftheria Evangelopoulos, et al.
Frontiers in Neurology|November 28, 2022
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvementSylvia Raftopoulou, Anna Rapti, Dimitris Karathanasis, et al.
Arthritis and Rheumatism|August 31, 2012
Brief report: adrenal autoimmunity in primary Sjögren's syndromeClio P Mavragani, Marian Schini, Fotini Gravani, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Clinical Immunology (Orlando, Fla.)|September 19, 2017
Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndromeAdrianos Nezos, Ilir Cinoku, Clio P Mavragani, et al.
The Journal of Rheumatology|February 17, 2007
Ill-defined neurological syndromes with autoimmune background: a diagnostic challengeClio P Mavragani, Nicholas Patronas, Marinos Dalakas, et al.
Mediterranean Journal of Rheumatology|August 27, 2021
B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated AtherosclerosisNikolaos Kintrilis, Adrianos Nezos, Evangelos Theodorou, et al.
American Journal of Hematology|May 28, 2004
Cutaneous ulcers: An unusual manifestation of inherited thrombophiliaClio P Mavragani, Dimitris Pikazis, Kyriaki Aroni, et al.
Journal of Clinical Medicine|June 12, 2026
Early Cardiac Involvement in Treatment-Naïve, Autoantibody-Seropositive Patients with Autoimmune Rheumatic Diseases in the Prodromal Phase-A Cardiovascular Magnetic Resonance StudyGeorge Markousis-Mavrogenis, Vasiliki Koulouri, Clio P Mavragani, et al.
Arthritis and Rheumatism|January 30, 2010
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohortClio P Mavragani, Dan T La, William Stohl, et al.
Arthritis Research & Therapy|November 10, 2010
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective studyKaterina Laskari, Clio P Mavragani, Athanasios G Tzioufas, et al.
Expert Review of Clinical Immunology|June 7, 2021
Type I interferon detection in autoimmune diseases: challenges and clinical applicationsVassilis E Papadopoulos, Charalampos Skarlis, Maria-Eleftheria Evangelopoulos, et al.
Frontiers in Neurology|November 28, 2022
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvementSylvia Raftopoulou, Anna Rapti, Dimitris Karathanasis, et al.
Arthritis and Rheumatism|August 31, 2012
Brief report: adrenal autoimmunity in primary Sjögren's syndromeClio P Mavragani, Marian Schini, Fotini Gravani, et al.
Pageof 12